Cambridge Biotechs Attract Venture Financing
- Posted by ISPE Boston
- On September 10, 2020
Cambridge-based startups Korro Bio and Casma Therapeutics have secured financing of $91.5 million and $50 million, respectively, in recent funding rounds. Both companies were launched in 2018. The funding will enable Korro to advance its novel platform for precise, single-base, RNA editing to modulate protein function for therapeutic applications, including advancing its lead program to […]
Read More